Emergent Biosolutions Competitors and Similar CompaniesClear all

Emergent Biosolutions's competitors and similar companies include Valneva and LTS Lohmann Therapie-Systeme.

	Emergent Biosolutions Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats.	Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.	LTS Lohmann Therapie-Systeme LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.
Founding Date	Founding Date 1998	Founding Date 2013	Founding Date 1984
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare drug development medtech pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare drug development pharma therapy
Locations	Locations Gaithersburg, US HQ Mississauga, CA Winnipeg, CA Dublin, IE London, GB Canton, US Lansing, US see more	Locations Saint-Herblain, FR HQ Wien, AT Kirkland, CA Lyon, FR Solna, SE Fleet, GB Livingston, GB see more	Locations Andernach, DE HQ Shanghai, CN West Caldwell, US
Employees	Employees 90044% decrease	Employees 713	Employees 2991% increase
Valuation ($)	Valuation ($) 493.6 m	Valuation ($) 482.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $742.9m (FY, 2025)	Revenue (est.) €157.9m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $326.2m (FY, 2025)	Cost of goods €8.2m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $416.7m (FY, 2025)	Gross profit €177.7m (FY, 2025)	Gross profit N/A
Net income	Net income $52.6m (FY, 2025)	Net income (€115.2m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 34.5m	Total funding raised $ 51.7m	Total funding raised N/A